Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Breast Cancer Female × Saline Solution × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 26 Pain, Postoperative 17 Parkinson Disease 4, Autosomal Dominant Lewy Body 12 Neoplasms 12 Lung Neoplasms 12 Brain Neoplasms 10 Prostatic Neoplasms 9 Ovarian Neoplasms 8 Colorectal Neoplasms 7 Colonic Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Carcinoma, Hepatocellular 7 Depression 6 Thyroid Neoplasms 5 Stomach Neoplasms 5 Pancreatic Neoplasms 5 Head and Neck Neoplasms 5 Pain 4 Multiple Myeloma 4 Lymphoma 4 Leiomyoma 4 Anxiety Disorders 4 Urinary Bladder Neoplasms 3 Thromboembolism 3 Supratentorial Neoplasms 3 Stomatitis 3 Rectal Neoplasms 3 Neoplasm Metastasis 3 Myofibroma 3 Lymphoma, Non-Hodgkin 3

Interventions

Tamoxifen 4 Exercise 3 pyrotinib 2 abemaciclib 2 Paclitaxel 2 Metformin 2 Cyclophosphamide 2 Capecitabine 2 Bupivacaine 2 Aromatase Inhibitors 2 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 palbociclib 1 iniparib 1 exemestane 1 durvalumab 1 darolutamide 1 Yoga 1 Waiting Lists 1 Vitamin D 1 Tretinoin 1 Trastuzumab 1 Tocopherols 1 Thioctic Acid 1 Standard of Care 1 Sodium Chloride 1 Self-Help Groups 1 Saline Solution 1 Ropivacaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03007381 2017-08-16

KANGAROO

Nova Scotia Health Authority

Phase 4 Withdrawn

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡